In the present cross-sectional study, we found that the prevalence of metabolic syndrome, hypertension, and diabetes was significantly higher in NAFLD subjects than in non-NAFLD, and NAFLD subjects had a significantly higher BMI, WC, waist-to-hip ratio, blood pressure, hemoglobin, platelets, ALT, fasting glucose, TC, LDL, TG, and uric acid, and lower creatinine and HDL. The gene discussed is GPT; the disease is metabolic syndrome.